Clinical Research Trials : Hepatitis B

Hepatitis B

1. GS-US-320-1092: Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection

  • Status: Open
  • PI: Dr. Eugene Schiff, Dr. Leslie Smith
  • Coordinator: Diane Sabogal
  • Contact: (305) 243-1501 / d.sabogal@med.miami.edu

2. ABI- H0731-201: A Phase 2a, Multi-center, Double-blind, Placebo-controlled Study Evaluating ABI-H0731 as Adjunctive Therapy in Virally-suppressed HBeAg-positive Patients with Chronic Hepatitis B

  • Status: Future Trial
  • PI: Dr. Eugene Schiff
  • Coordinator: Diane Sabogal
  • Contact: (305) 243-1501 / d.sabogal@med.miami.edu

3. ABI-H0731-202: A Phase 2a, Multi-center, Double-blind, Placebo-controlled Study Evaluating ABI-H0731 + Entecavir vs Entecavir Alone for the Treatment of Viremic, HBeAg-positive Patients eith Chronic Hepatitis B

  • Status: Future Trial
  • PI: Dr. Eugene Schiff
  • Coordinator: Diane Sabogal
  • Contact: (305) 243-1501 / d.sabogal@med.miami.edu

4. CTRV-CRV431-101: A Randomized , Partially-Blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Does Study of the Safety, Tolerability, and Pharmacokinetics of CRV431, Alone and in Combination with Tenofovir Desproxil Fumarate in Healthy Subjects, with a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment

  • Status: Future Trial
  • PI: Dr. Eugene Schiff
  • Coordinator: Diane Sabogal
  • Contact: (305) 243-1501 / d.sabogal@med.miami.edu